11L Stock Overview
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Canopy Growth Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$8.41 |
| 52 Week High | CA$18.79 |
| 52 Week Low | CA$2.55 |
| Beta | 2.03 |
| 1 Month Change | 24.41% |
| 3 Month Change | 98.07% |
| 1 Year Change | -28.33% |
| 3 Year Change | -96.21% |
| 5 Year Change | -98.06% |
| Change since IPO | -65.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| 11L | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 10.8% | 3.2% | 1.7% |
| 1Y | -28.3% | -28.2% | 2.3% |
Return vs Industry: 11L matched the German Pharmaceuticals industry which returned -28.2% over the past year.
Return vs Market: 11L underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| 11L volatility | |
|---|---|
| 11L Average Weekly Movement | 28.5% |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 11L's share price has been volatile over the past 3 months.
Volatility Over Time: 11L's weekly volatility (28%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 1,621 | David Klein | www.canopygrowth.com |
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company’s products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes.
Canopy Growth Corporation Fundamentals Summary
| 11L fundamental statistics | |
|---|---|
| Market cap | €618.98m |
| Earnings (TTM) | -€804.84m |
| Revenue (TTM) | €247.06m |
2.5x
P/S Ratio-0.8x
P/E RatioIs 11L overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 11L income statement (TTM) | |
|---|---|
| Revenue | CA$362.24m |
| Cost of Revenue | CA$322.10m |
| Gross Profit | CA$40.15m |
| Other Expenses | CA$1.22b |
| Earnings | -CA$1.18b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -15.95 |
| Gross Margin | 11.08% |
| Net Profit Margin | -325.76% |
| Debt/Equity Ratio | 112.4% |
How did 11L perform over the long term?
See historical performance and comparison